Skip to main content
. 2013 Nov 6;8(11):e77961. doi: 10.1371/journal.pone.0077961

Table 4. Predictors of Mistimed Doses.

Mistimed 2nd Dose Mistimed 3rd Dose
OR (95% CI) aOR (95% CI) OR (95% CI) aOR (95% CI)
Age 0.94 (0.90, 0.99) 0.94 (0.89–0.99) 0.97 (0.93, 1.01) 0.97 (0.93–1.02)
Race
White Referent Referent Referent Referent
Black 1.70 (1.11, 2.61) 2.14 (1.38–3.34) 1.31 (0.90, 1.90) 1.52 (1.03–2.24)
Hispanic 1.66 (0.77, 3.56) 1.94 (0.89–4.22) 2.44 (1.19, 5.00) 2.80 (1.35–5.79)
Gravidity
n = 0 Referent
n≥1 0.86 (0.58, 1.27) § 0.97 (0.68, 1.37) §
Parity
n = 0 Referent § §
n≥1 0.79 (0.53, 1.16) 0.91 (0.64, 1.28)
Visit Type at first dose
HPV4-only Referent Referent Referent Referent
Other Health Care Visit Types 3.32 (2.28, 4.83) 3.53 (2.39–5.23) 1.87 (1.33, 2.62) 1.97 (1.39–2.80)
Visit Type at first dose
HPV4-only Referent § §
Acute Illness 1.85 (0.89, 3.86) 1.18 (0.59, 2.36)
Follow up from acute illness 3.81 (1.73, 8.39) 1.08 (0.42, 2.79)
Preventive Visit 3.97 (2.39, 6.60) 2.96 (1.90, 4.62)
Postpartum 3.90 (2.37, 6.40) 1.52 (0.78, 2.97)
Other* 2.71 (1.29, 5.69) 1.83 (0.93, 3.60)

N = 124 mistimed second doses among all doses delivered; N = 153 mistimed third doses among all doses delivered.

*

Counseling for smoking cessation, depression, or contraceptive use; and Procedures including IUD placement.

‡adjusted for significant variables in univariate model.

§Not included in multivariate model due to lack of significance or co-linearity.

Bold font indicates a significant predictor.